In a regulatory filing, Repligen CFO Jon Snodgres disclosed the sale of 5,647 common shares of the company on February 16 at a price of $200 per share.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on RGEN:
In a regulatory filing, Repligen CFO Jon Snodgres disclosed the sale of 5,647 common shares of the company on February 16 at a price of $200 per share.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on RGEN: